Big Data Analytics in Chemoinformatics and Bioinformatics: With Applications to Computer-Aided Drug Design, Cancer Biology, Emerging Pathogens and Com

ISBN 10: 0323857132 / ISBN 13: 9780323857130

Published by Elsevier Science & Technology|Elsevier, 2022

About this Item

Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Big Data Analytics in Chemoinformatics and Bioinformatics: With Applications to Computer-Aided Drug Design, Cancer Biology, Emerging Pathogens and Computational Toxicology provides an up-to-date presentation of big data analytics methods and their.

Seller Inventory # 487329865

Bibliographic Details

• Title: Big Data Analytics in Chemoinformatics and Bioinformatics: With Applications to Computer-Aided Drug Design, Cancer Biology, Emerging Pathogens and Com
• Publisher: Elsevier Science & Technology|Elsevier
• Publication Date: 2022
• Language: English
• ISBN 10: 0323857132
• ISBN 13: 9780323857130
• Binding: Soft cover
• Condition: New

About this title

Synopsis

Big Data Analytics in Chemoinformatics and Bioinformatics: With Applications to Computer-Aided Drug Design, Cancer Biology, Emerging Pathogens and Computational Toxicology provides an up-to-date presentation of big data analytics methods and their applications in diverse fields. The proper management of big data for decision-making in scientific and social issues is of paramount importance. This book gives researchers the tools they need to solve big data problems in these fields. It begins with a section on general topics that all readers will find useful and continues with specific sections covering a range of interdisciplinary applications.

Here, an international team of leading experts review their respective fields and present their latest research findings, with case studies used throughout to analyze and present key information.

• Brings together the current knowledge on the most important aspects of big data, including analysis using deep learning and fuzzy logic, transparency and data protection, disparate data analytics, and scalability of the big data domain
• Covers many applications of big data analysis in diverse fields such as chemistry, chemoinformatics, bioinformatics, computer-assisted drug/vaccine design, characterization of emerging pathogens, and environmental protection
• Highlights the considerable benefits offered by big data analytics to science, in biomedical fields and in industry

About the Authors

Dr. Basak is an adjunct professor in the department of chemistry and department of biochemistry & molecular biology at the University of Minnesota Duluth. He received his Ph.D. in Biochemistry from the University of Calcutta in 1980. He is a member of several academic societies, including International Society for Mathematical Chemistry, of which he is President, and is a US Chair in the organization of thirteen international mathematical chemistry workshops in USA, South America, and various universities/ research institutes in India. He was awarded ARA Journal Best Paper Award, American Romanian Academy of Arts and Sciences (2004) and Statistics in Chemistry Award, American Statistical Association (2004).

is senior researcher at Kemijski Inštitut/National Institute of Chemistry in Ljubljana, Slovenia. Since 1994 his research has been focused on QSAR (quantitative structure-activity relationship) modelling of biological/toxical properties of compounds, to quantum chemistry, to chemometrics (numerical analysis of proteomic and genomic data) and to modeling of interaction between receptors and molecules. He obtained his PhD (1990) from University of Erlangen, FR Germany in the field of quantum chemistry. Later on, he was a post doc at the Columbia University of New York and at the University of Namur, BE (Faculté Universitaire Notre Dame de la Paix, Namur). In 1994 he joined the National Institute of Chemistry in Ljubljana. In 2005 he was senior visiting researcher at the Joint Research Centre of European Commission, Ispra where he worked on applications of (Q)SAR methods for regulatory purposes. He is author of 85 scientific papers and chapters